Enveric Biosciences ENVB
NASDAQ ENVB
$1.46 -0.02 (-1.68%)
At close: Oct 1, 2026 · 4:00 PM EDT

Enveric Biosciences (ENVB) Non Operating Interest Expenses (2015 - 2023)

Updated

Enveric Biosciences (ENVB) posted Non Operating Interest Expenses of $11.00 for Q1 2023, down 99.7% from $4,138 a year earlier and down 91.9% from the prior quarter.

Analysis

Enveric Biosciences (ENVB) Non Operating Interest Expenses (2015 - 2023) Analysis & Trends

For the trailing twelve months through Mar 31, 2023, Non Operating Interest Expenses at Enveric Biosciences was $1,122, down 92.2% year-over-year; for FY2022, it was $5,249, down 49.1% from FY2021.

  • Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of -60.9% (FY2017 to FY2022).
  • In prior years, Enveric Biosciences' Non Operating Interest Expenses was $10,316 in FY2021 (-97.7%), $445,250 in FY2020 (+444.2%), $81,823 in FY2019 (-88.8%) and $729,896 in FY2018 (+26.9%).
  • The Q1 2023 figure stands as the lowest quarterly Non Operating Interest Expenses since Q4 2019.
  • On a year-over-year basis, Non Operating Interest Expenses has declined in each of the last four quarters, with an average decline of 83.0% over the last seven quarters.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q1 2020, with growth of 83.6%; the weakest was Q1 2023, with a decline of 99.7%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $135.00 (Q4 2022), $308.00 (Q3 2022) and $668.00 (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Enveric Biosciences 5.86 Mn -15.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 11.00
Dec 31, 2022 135.00
Sep 30, 2022 308.00
Jun 30, 2022 668.00
Mar 31, 2022 4,138.00
Dec 31, 2021 5,125.00
Sep 30, 2021 370.00
Jun 30, 2021 4,821.00
Dec 31, 2020 57,107.00
Sep 30, 2020 75,501.00
Jun 30, 2020 50,883.00
Mar 31, 2020 261,759.00
Dec 31, 2019 -470,039.00
Sep 30, 2019 252,648.00
Jun 30, 2019 156,660.00
Mar 31, 2019 142,554.00
Dec 31, 2018 145,822.00
Sep 30, 2018 190,394.00
Jun 30, 2018 182,521.00
Mar 31, 2018 211,159.00
API Access

Enveric Biosciences Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ENVB&period=max&api_key=YOUR_API_KEY